中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/09 | 3,547 | 3,648 | 3,547 | 3,633 | +26 | +0.7% | 2,484,300 |
| 2022/12/08 | 3,670 | 3,670 | 3,579 | 3,607 | -43 | -1.2% | 1,776,300 |
| 2022/12/07 | 3,638 | 3,662 | 3,630 | 3,650 | +3 | +0.1% | 1,874,700 |
| 2022/12/06 | 3,607 | 3,665 | 3,603 | 3,647 | +37 | +1% | 2,021,500 |
| 2022/12/05 | 3,587 | 3,610 | 3,558 | 3,610 | +40 | +1.1% | 1,563,800 |
| 2022/12/02 | 3,621 | 3,624 | 3,547 | 3,570 | -86 | -2.4% | 2,253,100 |
| 2022/12/01 | 3,685 | 3,714 | 3,641 | 3,656 | +32 | +0.9% | 2,166,200 |
| 2022/11/30 | 3,603 | 3,653 | 3,591 | 3,624 | -24 | -0.7% | 4,878,900 |
| 2022/11/29 | 3,625 | 3,666 | 3,603 | 3,648 | -7 | -0.2% | 1,853,700 |
| 2022/11/28 | 3,649 | 3,664 | 3,623 | 3,655 | +24 | +0.7% | 1,983,900 |
| 2022/11/25 | 3,673 | 3,690 | 3,614 | 3,631 | -29 | -0.8% | 1,555,800 |
| 2022/11/24 | 3,634 | 3,681 | 3,627 | 3,660 | +56 | +1.6% | 2,791,000 |
| 2022/11/22 | 3,555 | 3,604 | 3,555 | 3,604 | +92 | +2.6% | 2,971,600 |
| 2022/11/21 | 3,467 | 3,520 | 3,464 | 3,512 | +38 | +1.1% | 2,613,200 |
| 2022/11/18 | 3,467 | 3,486 | 3,438 | 3,474 | +23 | +0.7% | 2,306,400 |
| 2022/11/17 | 3,435 | 3,477 | 3,428 | 3,451 | +23 | +0.7% | 2,513,100 |
| 2022/11/16 | 3,461 | 3,462 | 3,397 | 3,428 | -21 | -0.6% | 2,202,400 |
| 2022/11/15 | 3,472 | 3,517 | 3,445 | 3,449 | -59 | -1.7% | 2,871,300 |
| 2022/11/14 | 3,471 | 3,533 | 3,456 | 3,508 | +72 | +2.1% | 3,129,400 |
| 2022/11/11 | 3,392 | 3,439 | 3,378 | 3,436 | +77 | +2.3% | 3,439,100 |
| 2022/11/10 | 3,350 | 3,366 | 3,337 | 3,359 | -22 | -0.7% | 2,033,800 |
| 2022/11/09 | 3,378 | 3,389 | 3,357 | 3,381 | -5 | -0.1% | 2,722,600 |
| 2022/11/08 | 3,400 | 3,423 | 3,378 | 3,386 | +16 | +0.5% | 2,135,200 |
| 2022/11/07 | 3,335 | 3,383 | 3,335 | 3,370 | +28 | +0.8% | 2,184,500 |
| 2022/11/04 | 3,365 | 3,389 | 3,335 | 3,342 | -88 | -2.6% | 3,533,300 |
| 2022/11/02 | 3,420 | 3,438 | 3,402 | 3,430 | -21 | -0.6% | 2,957,200 |
| 2022/11/01 | 3,465 | 3,480 | 3,437 | 3,451 | +1 | ±0% | 2,006,000 |
| 2022/10/31 | 3,435 | 3,470 | 3,430 | 3,450 | +27 | +0.8% | 2,501,700 |
| 2022/10/28 | 3,418 | 3,442 | 3,399 | 3,423 | -28 | -0.8% | 6,391,400 |
| 2022/10/27 | 3,476 | 3,476 | 3,427 | 3,451 | -14 | -0.4% | 2,400,400 |
| 2022/10/26 | 3,402 | 3,501 | 3,397 | 3,465 | +69 | +2% | 4,025,200 |
| 2022/10/25 | 3,492 | 3,499 | 3,393 | 3,396 | -123 | -3.5% | 5,757,500 |
| 2022/10/24 | 3,604 | 3,615 | 3,519 | 3,519 | -52 | -1.5% | 2,120,300 |
| 2022/10/21 | 3,588 | 3,628 | 3,558 | 3,571 | -33 | -0.9% | 1,798,100 |
| 2022/10/20 | 3,617 | 3,640 | 3,591 | 3,604 | -51 | -1.4% | 1,946,400 |
| 2022/10/19 | 3,760 | 3,769 | 3,647 | 3,655 | -63 | -1.7% | 2,212,800 |
| 2022/10/18 | 3,750 | 3,761 | 3,709 | 3,718 | +45 | +1.2% | 2,180,100 |
| 2022/10/17 | 3,724 | 3,739 | 3,658 | 3,673 | -111 | -2.9% | 2,147,700 |
| 2022/10/14 | 3,729 | 3,803 | 3,708 | 3,784 | +85 | +2.3% | 2,969,200 |
| 2022/10/13 | 3,748 | 3,775 | 3,698 | 3,699 | -31 | -0.8% | 1,705,200 |
| 2022/10/12 | 3,710 | 3,766 | 3,689 | 3,730 | +31 | +0.8% | 2,197,300 |
| 2022/10/11 | 3,737 | 3,748 | 3,676 | 3,699 | -78 | -2.1% | 2,174,600 |
| 2022/10/07 | 3,753 | 3,797 | 3,727 | 3,777 | -24 | -0.6% | 1,943,200 |
| 2022/10/06 | 3,800 | 3,834 | 3,769 | 3,801 | -7 | -0.2% | 2,061,600 |
| 2022/10/05 | 3,812 | 3,829 | 3,765 | 3,808 | +18 | +0.5% | 2,685,800 |
| 2022/10/04 | 3,735 | 3,790 | 3,707 | 3,790 | +120 | +3.3% | 2,710,800 |
| 2022/10/03 | 3,613 | 3,671 | 3,580 | 3,670 | +44 | +1.2% | 2,366,200 |
| 2022/09/30 | 3,637 | 3,679 | 3,608 | 3,626 | -4 | -0.1% | 4,237,200 |
| 2022/09/29 | 3,526 | 3,630 | 3,525 | 3,630 | +150 | +4.3% | 2,832,200 |
| 2022/09/28 | 3,406 | 3,482 | 3,406 | 3,480 | +48 | +1.4% | 4,064,000 |
651～
700
件表示中 / 3756件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 735,800円 | +1.7% | +5.0% | 3.40% | 29.53倍 | 6.10倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 356,600円 | +6.0% | +4.0% | 2.19% | 22.00倍 | 4.07倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 421,400円 | -1.1% | +75.3% | 4.75% | 29.19倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 741,700円 | +2.2% | +28.0% | 1.89% | 11.87倍 | 1.44倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 158,000円 | +0.9% | +380.2% | 4.94% | 21.77倍 | 1.87倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
